House Oversight Committee Chairman Trey Gowdy became the latest Republican to say he’s leaving politics. Cenk Uygur, the CEO of The Young Turks, called the recent trend “unprecedented.” "That means their poll numbers are disastrous. They think 2018 is going to be a landslide and a complete wipeout," Uygur told Cheddar. Gowdy, a Republican from South Carolina, said in a tweet Wednesday that he wouldn’t run for re-election in the 2018 midterms and would instead return to the justice system. His decision carries even more importance considering his position on the Oversight Committee, which has not yet completed its investigation into Russian interference in the 2016 election. The previous Chair, Jason Chaffetz, stepped down in June. "It would be shocking if it was a coincidence that everybody in Oversight is now saying, ‘I gotta get the hell out of there,’" Uygur said. The loss of Gowdy comes as the GOP is increasingly at odds over how to work with the Trump administration. Some Republicans in Congress are trying to rein him in while others are standing behind him. Uygur speculates this sentiment has motivated Republicans to step down. For full interview, [click here](https://cheddar.com/videos/young-turks-founder-cenk-uygur-weighs-in-on-rep-trey-gowdys-retirement).

Share:
More In Politics
Skydio CEO On Russia-US Drone Collision
Adam Bry, co-founder and CEO of drone manufacturer Skydio, joined Cheddar News to discuss the company's latest funding round and the Russia-US drone collision.
Fed Set to Launch Digital Payments System Over the Summer
The Federal Reserve on Wednesday evening said its long-awaited digital payment system, the FedNow Service, will start operating in July. The service is designed to provide a national platform for financial institutions to settle payments in real-time and at lower cost. That could include large banks, payment processors, and the U.S. Treasury.
Long-Used US Abortion Pill Under Threat in Texas Lawsuit
A federal judge in Texas raised questions Wednesday about a Christian group's effort to overturn the decades-old U.S. approval of a leading abortion drug, in a case that could threaten the country's most common method for ending pregnancies.
Load More